Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications evaluation risk minimisation activities cyproterone acetate 2 mgethinylestradiol 35 µg
… identifying appropriate treatment stopping rules, finding publications reporting stratified cost and utility estimates, …
… Publication Management and Medical Writing Publications are critical for the dissemination of your … and internal milestones is an integral part of the publications process. We develop a customized timeline for … meet your compliance requirements. Publication development activities include: Early Development Collaborating with …
… information that can help you understand and communicate risk tolerance from patients and other stakeholders to inform … can also help catalog issues that could arise in benefit-risk assessments . Additionally, the decision process can be …
… outcomes research, patient preference, and economic evaluation, to reimbursement and safety activities. We start with your research questions and help …
… Using Primary Data Collection To meet the requirements of risk management programs, inform drug development and … of patients, physicians, and caregivers Evaluate risk management programs including REMS and EU-RMPs Depending …
… operations, and we comply with data protection laws in all activities. Our standard operating procedures outline the … Data Processing Data Protection Security and Controls Risk Management Data Breach Management Records Management The … is approved for processing EU personal data. This GDPR evaluation is in addition to the qualification by the RTI-HS …
… experience in the rigorous development and psychometric evaluation of clinical outcome assessment measures for use in …
… to 3 different treatment strategies on the 12-year risk of dementia. The first two strategies involved the … both an increase of 1.6% and a decrease of approximately 2% in the risk of dementia after 12 years of follow-up when comparing …
… HCPs towards hepatitis A and B vaccination of adults at risk. Shamarina D, Sluga-O'Callaghan M, Dave V, Davenport E, …
… positioning of your product, you should begin in Phase 2 of clinical development. Tasks to support the strategy should include the following activities. …